137 related articles for article (PubMed ID: 30370853)
1. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
[TBL] [Abstract][Full Text] [Related]
2. The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists.
Xu G; Chu Y; Jiang N; Yang J; Li F
Int J Mol Sci; 2012; 13(5):6138-6155. PubMed ID: 22754355
[TBL] [Abstract][Full Text] [Related]
3. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Balupuri A; Balasubramanian PK; Cho SJ
Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers.
Ghrifi F; Allam L; Wiame L; Ibrahimi A
J Comput Biol; 2019 Oct; 26(10):1156-1167. PubMed ID: 31009237
[No Abstract] [Full Text] [Related]
6. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
8. Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.
Yuan M; Luo M; Song Y; Xu Q; Wang X; Cao Y; Bu X; Ren Y; Hu X
Bioorg Med Chem; 2011 Feb; 19(3):1189-96. PubMed ID: 21237663
[TBL] [Abstract][Full Text] [Related]
9. Computational analyses of curcuminoid analogs against kinase domain of HER2.
Yim-im W; Sawatdichaikul O; Semsri S; Horata N; Mokmak W; Tongsima S; Suksamrarn A; Choowongkomon K
BMC Bioinformatics; 2014 Aug; 15(1):261. PubMed ID: 25089037
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
12. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
[TBL] [Abstract][Full Text] [Related]
14. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity.
Shi Q; Shih CC; Lee KH
Anticancer Agents Med Chem; 2009 Oct; 9(8):904-12. PubMed ID: 19663790
[TBL] [Abstract][Full Text] [Related]
17. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
Abdizadeh T; Ghodsi R; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
[TBL] [Abstract][Full Text] [Related]
19. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
Chen H; Zhang J; Hu P; Qian Y; Li J; Shen J
Bioorg Med Chem; 2019 Oct; 27(20):115081. PubMed ID: 31493989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
